ACTIVE SUBSTANCE / INN

PALIPERIDONE PALMITATE

Brand name(s): INVEGA SUSTENNA, INVEGA TRINZA, ERZOFRI, PALIPERIDONE PALMITATE, INVEGA HAFYERA
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
NDA216352
ANDA210397
ACTIVE SUBSTANCE
Paliperidone Palmitate
REGULATORS
FDA
SPONSORS / MAH
LUYE INNOMIND PHARMA, PHARMASCIENCE INC, JANSSEN PHARMS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PALIPERIDONE PALMITATEANDA210397PHARMASCIENCE INCNone (Tentative Approval)
ERZOFRINDA216352LUYE INNOMIND PHARMAPrescription
INVEGA SUSTENNANDA022264JANSSEN PHARMSPrescription
INVEGA HAFYERANDA207946JANSSEN PHARMSPrescription
INVEGA TRINZANDA207946JANSSEN PHARMSPrescription

FULL INTELLIGENCE ON PALIPERIDONE PALMITATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →